The invention concerns human thrombopoietin and in particular modified forms of thrombopoietin (TPO) with improved properties. The improved proteins contain amino acid substitutions at specific positions within the TPO molecule. The invention provides modified TPO molecules, preferably fusion proteins comprising immunoglobulin constant regions and modified human TPO, with improved biological activity concomitant with reduced immunogenic potential in the protein. The improved proteins are intended for therapeutic use in the treatment of diseases in humans.

 
Web www.patentalert.com

< Mild, viscous cleansing composition with versatile compatibility and enhanced conditioning

> Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease

> Conjugates with reduced adverse systemic effects

~ 00522